Cite
MLA Citation
Federica Miglietta et al.. “Validation of Residual Proliferative Cancer Burden as a Predictor of Long‐Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor‐Positive/Human Epidermal Growth Receptor 2‐Negative Breast Cancer.” Oncologist, vol. 25, 2020, pp. e1355–e1362. http://access.bl.uk/ark:/81055/vdc_100109902052.0x000030